Independent assessment supports a role for tamoxifen in breast cancer risk reduction.
D000328:Adult; D000367:Age Factors; D016588:Anticarcinogenic Agents / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000453:epidemiology / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008875:Middle Aged; D015995:Prevalence; D018570:Risk Assessment; D012307:Risk Factors; D013629:Tamoxifen / Q000008:administration & dosage*; D014481:United States / Q000453:epidemiology
D016588:Anticarcinogenic Agents; D013629:Tamoxifen